Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $8.4400 (-6.43%) ($8.4400 - $8.4400) on Mon. Mar. 14, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.83% (three month average) | RSI | 18 | Latest Price | $8.4400(-6.43%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -0.3% a day on average for past five trading days. | Weekly Trend | ATRA declines -17.4% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(50%) IBB(47%) ARKG(46%) ARKK(46%) IWO(42%) | Factors Impacting ATRA price | ATRA will decline at least -2.415% in a week (0% probabilities). VIXM(-40%) VXX(-29%) UNG(-17%) EDOC(-13%) USO(-9%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.415% (StdDev 4.83%) | Hourly BBV | -2 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-24.66(-392.18%) | Resistance Level | $11.24 | 5 Day Moving Average | $9(-6.22%) | 10 Day Moving Average | $9.15(-7.76%) | 20 Day Moving Average | $11.24(-24.91%) | To recent high | -51.2% | To recent low | 0% | Market Cap | $627m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |